Examples of using Development study in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
In a rat pre- and postnatal development study, the no observed effect dose was 30 mg/ kg/ day.
Sunitinib(0.3, 1.0, 3.0 mg/kg/day)was evaluated in a pre-and postnatal development study in pregnant rats.
An embryofoetal development study has been conducted in monkeys administered lenalidomide at doses up to 4 mg/kg/day.
In pregnant rabbits, gross lesions of the stomach and intestines were observed in dead or moribund does at maternal doses 2 and4 times the highest dose administered in the definitive embryo- development study.
An embryofoetal development study has been conducted in monkeys administered lenalidomide at doses from 0.5 and up to 4 mg/kg/day.
The range of products is truly overwhelming and instead of facilitating an individual product choice appropriate to the child's personality and affinity, the demands on parents grow with every new technological innovation andnewly released development study.
The evaluation of the peri- and postnatal development study in rats is hampered due to subsequent administration of DPH, and therefore of limited relevance.
Dose-dependent skin alterations, starting at dose levels equivalent tothose used in humans, were the major findings observed in toxicity studies with Cynomolgus monkeys a chronic repeat-dose toxicity study and an embryo-foetal development study.
In a prenatal and postnatal development study in rats an increase of the duration of gestation and a slight increase in the incidence of peri-natal pup mortality was found.
However, at a maternally toxic dose of 60 mg/kg/day(6 times the human clinical exposure in ITP patients at 75 mg/day and 3 times the human clinical exposure in HCV patients at 100 mg/day, based on AUC) in rats,eltrombopag treatment was associated with embryo lethality(increased pre- and post-implantation loss), reduced foetal body weight and gravid uterine weight in the female fertility study and a low incidence of cervical ribs and reduced foetal body weight in the embryofoetal development study.
In a pre- and post-natal development study, a slightly prolonged gestation period, reduced number of implantation sites, and reduced number of pups delivered were observed.
In the rat, no adverse effects were observed in a pre- and post-natal development study at maternal plasma exposure(AUC) similar to humans and exposure in the offspring 3-fold higher than in adult humans.
In an embryo-foetal development study in rats, ossification delays of metatarsal bones were observed at systemic exposures 73 times and 19 times higher than the clinical exposures at the 100 mg and 300 mg doses.
In a pre- and post-natal development study in rats, an increase in stillborn pups and reduced embryo/ fetal survival was seen at maternally toxic doses≥ 3 mg/ kg.
In a pre- and postnatal development study in rats, limited changes in immune function were observed at 19-fold a human 10 mg/kg dose based on AUC see section 5.3.
In a pre- and postnatal development study in rats, exposures far above the human exposure at the recommended dose did not harm the developing embryo or affect offspring growth and development. .
In the rat peri- and post-natal development study with tafamidis, decreased pup survival and reduced pup weights were noted following maternal treatment during pregnancy and lactation at doses of 15 and 30 mg/kg.
In an embryo-foetal development study in rats, increased post-implantation loss, malformations(absence of caudal vertebrae and in some cases also of sacral vertebrae), skeletal variations and lower foetal body weights were observed.
An embryofetal development study in pregnant rats did not indicate a teratogenic effect attributed to the co-administration of linagliptin and metformin at AUC exposure levels up to 4 and 30 times human exposure, respectively.
In a pre- and postnatal development study, canagliflozin administered to female rats from gestation day 6 to lactation day 20 resulted in decreased body weights in male and female offspring at maternally toxic doses> 30 mg/kg/day exposures≥ 5.9 times the human exposure to canagliflozin at the MHRD.
We offer capacity development studies, mentoring, consulting- development of leaders, teams and organizations.
Peri- and postnatal development studies were not conducted.
The main findings in rabbit embryofetal development studies included malformations of the heart(dilated aorta, cardiomegaly) at systemic exposures 36-fold higher than observed at the MHRD.
Embryo-foetal development studies in mice and rats showed no evidence of a teratogenic effect at exposure levels 4-fold and 6-fold, respectively, those expected in humans.
In embryo-foetal development studies in mice and rats, reductions in maternal body weight were found only in mice.
Four embryo-fetal development studies were performed in rabbits covering doses of 200, 600, 800, 1200 and 1800 mg/kg/day.
Sofosbuvir had no effects on embryo-foetal viability oron fertility in rat and was not teratogenic in rat and rabbit development studies.
Status epilepticus cases have been observed during clinical development studies, under rufinamide whereas no such cases have been observed under placebo.
In embryo-foetal development studies no undesirable effects were observed at doses up to 29-fold a human 10 mg/ kg dose based on AUC.
Education and Arts- areas include education, arts and humanities,global studies and international development studies, media communications, social science, youth work, and creative arts, visual arts and design.